1-16 of 16
Jeffery L. Kutok
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

EZH2 Cooperates with BRD4-NUT to Drive NUT Carcinoma Growth by Silencing Key Tumor Suppressor Genes

Yeying Huang, R. Taylor Durall, Nhi M. Luong, Hans J. Hertzler, Julianna Huang, Prafulla C. Gokhale, Brittaney A. Leeper, Nicole S. Persky, David E. Root, Praju V. Anekal, Paula D.L.M. Montero Llopis, Clement N. David, Jeffery L. Kutok, Alejandra Raimondi, Karan Saluja, Jia Luo, Cynthia A. Zahnow, Biniam Adane, Kimberly Stegmaier, Catherine E. Hawkins, Christopher Ponne, Quan Le, Geoffrey I. Shapiro, Madeleine E. Lemieux, Kyle P. Eagen, Christopher A. French
Journal: Cancer Research
Cancer Res (2023) 83 (23): 3956–3973.
https://doi.org/10.1158/0008-5472.CAN-23-1475
Published: 01 December 2023
View article titled, EZH2 Cooperates with BRD4-NUT to Drive NUT Carcinoma Growth by Silencing Key Tumor Suppressor Genes
Open the PDF for EZH2 Cooperates with BRD4-NUT to Drive NUT Carcinoma Growth by Silencing Key Tumor Suppressor Genes in another window
Includes: Supplementary data
Journal Articles

Abstract 4933: Duvelisib eliminates CLL B Cells, impairs CLL-supporting cells, and overcomes ibrutinib resistance in a patient-derived xenograft model

Shih-Shih Chen, Jacqueline C. Barrientos, Gerardo Ferrer, Priyadarshini Ravichandran, Michael Ibrahim, Yasmine Kieso, Jeffery L. Kutok, Marisa Peluso, Sujata Sharma, David T. Weaver, Jonathan A. Pachter, Kanti R. Rai, Nicholas Chiorazzi
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 4933.
https://doi.org/10.1158/1538-7445.AM2023-4933
Published: 04 April 2023
View article titled, Abstract 4933: Duvelisib eliminates CLL B Cells, impairs CLL-supporting cells, and overcomes ibrutinib resistance in a patient-derived xenograft model
Journal Articles

Abstract ND12: Discovery and First Structural Disclosure of EZM0414: A potent and selective small molecule inhibitor of the histone methyltransferase SETD2

Jeffery L. Kutok
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): ND12.
https://doi.org/10.1158/1538-7445.AM2022-ND12
Published: 15 June 2022
View article titled, Abstract ND12: Discovery and First Structural Disclosure of EZM0414: A potent and selective small molecule inhibitor of the histone methyltransferase SETD2
Journal Articles

Abstract 554: Checkpoint blockade therapy is improved by altering the immune suppressive microenvironment with IPI-549, a potent and selective inhibitor of PI3K-gamma, in preclinical models

Olivier De Henau, Taha Merghoub, David Winkler, Sujata Sharma, Melissa Pink, Jeremy Tchaicha, Matthew Rausch, Jennifer Proctor, Nicole Kosmider, John Soglia, Vito Palombella, Jeffery L. Kutok, Jedd D. Wolchok, Karen McGovern
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 554.
https://doi.org/10.1158/1538-7445.AM2016-554
Published: 15 July 2016
View article titled, Abstract 554: Checkpoint blockade therapy is improved by altering the immune suppressive microenvironment with IPI-549, a potent and selective inhibitor of PI3K-gamma, in preclinical models
Journal Articles

Abstract 376: Combination of duvelisib with either ibrutinib or dexamethasone prevents mTOR-dependent feedback in aggressive B-cell lymphoma cell lines

Kerry White, Erin Murphy, Kerrie Faia, Jennifer Proctor, Nicole Kosmider, Melissa Pink, Stanley Goldstein, Karen McGovern, Jeffery L. Kutok
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 376.
https://doi.org/10.1158/1538-7445.AM2016-376
Published: 15 July 2016
View article titled, Abstract 376: Combination of duvelisib with either ibrutinib or dexamethasone prevents mTOR-dependent feedback in aggressive B-cell lymphoma cell lines
Journal Articles

A Unique Galectin Signature in Human Prostate Cancer Progression Suggests Galectin-1 as a Key Target for Treatment of Advanced Disease

Diego J. Laderach, Lucas D. Gentilini, Laura Giribaldi, Victor Cardenas Delgado, Lorena Nugnes, Diego O. Croci, Nader Al Nakouzi, Paula Sacca, Gabriel Casas, Osvaldo Mazza, Margaret A. Shipp, Elba Vazquez, Anne Chauchereau, Jeffery L. Kutok, Scott J. Rodig, María T. Elola, Daniel Compagno, Gabriel A. Rabinovich
Journal: Cancer Research
Cancer Res (2013) 73 (1): 86–96.
https://doi.org/10.1158/0008-5472.CAN-12-1260
Published: 02 January 2013
View article titled, A Unique Galectin Signature in Human Prostate Cancer Progression Suggests Galectin-1 as a Key Target for Treatment of Advanced Disease
Open the PDF for A Unique Galectin Signature in Human Prostate Cancer Progression Suggests Galectin-1 as a Key Target for Treatment of Advanced Disease in another window
Includes: Supplementary data
Journal Articles

Abstract 4252: Activated ALK collaborates with MYCN in neuroblastoma pathogenesis

Shizhen Zhu, Jeong-Soo Lee, Feng Guo, Jimann Shin, Antonio R. Perez-Atayde, Jeffery L. Kutok, Scott J. Rodig, Donna S. Neuberg, Daniel Helman, Hui Feng, Rodney A. Stewart, Wenchao Wang, Rani E. George, John Kanki, A Thomas Look
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 4252.
https://doi.org/10.1158/1538-7445.AM2012-4252
Published: 15 April 2012
View article titled, Abstract 4252: Activated ALK collaborates with MYCN in neuroblastoma pathogenesis
Journal Articles

Abstract 4296: Activated ALK accelerates the onset of neuroblastoma in MYCN-transgenic zebrafish

Shizhen Zhu, Jeong-Soo Lee, Jimann Shin, Antonio R. Perez-Atayde, Jeffery L. Kutok, Scott J. Rodig, Donna S. Neuberg, Feng Guo, Daniel Helman, Hui Feng, Rodney A. Stewart, Wenchao Wang, Rani E. George, John P. Kanki, A. Thomas Look
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 4296.
https://doi.org/10.1158/1538-7445.AM2011-4296
Published: 15 April 2011
View article titled, Abstract 4296: Activated ALK accelerates the onset of neuroblastoma in MYCN-transgenic zebrafish
Journal Articles

Serologic Markers of Effective Tumor Immunity against Chronic Lymphocytic Leukemia Include Nonmutated B-Cell Antigens

Ovidiu Marina, Ursula Hainz, Melinda A. Biernacki, Wandi Zhang, Ann Cai, Jonathan S. Duke-Cohan, Fenglong Liu, Vladimir Brusic, Donna Neuberg, Jeffery L. Kutok, Edwin P. Alyea, Christine M. Canning, Robert J. Soiffer, Jerome Ritz, Catherine J. Wu
Journal: Cancer Research
Cancer Res (2010) 70 (4): 1344–1355.
https://doi.org/10.1158/0008-5472.CAN-09-3143
Published: 14 February 2010
View article titled, Serologic Markers of Effective Tumor Immunity against Chronic Lymphocytic Leukemia Include Nonmutated B-Cell Antigens
Open the PDF for Serologic Markers of Effective Tumor Immunity against Chronic Lymphocytic Leukemia Include Nonmutated B-Cell Antigens in another window
Includes: Supplementary data
Journal Articles

Proteasome Inhibition Causes Regression of Leukemia and Abrogates BCR-ABL–Induced Evasion of Apoptosis in Part through Regulation of Forkhead Tumor Suppressors

Zainab Jagani, Keli Song, Jeffery L. Kutok, M. Rajan Dewar, Armelle Melet, Tanya Santos, Alexandra Grassian, Saghi Ghaffari, Catherine Wu, Ruibao Ren, Heather Yeckes Rodin, Kenneth Miller, Roya Khosravi-Far
Journal: Cancer Research
Cancer Res (2009) 69 (16): 6546–6555.
https://doi.org/10.1158/0008-5472.CAN-09-0605
Published: 12 August 2009
View article titled, Proteasome Inhibition Causes Regression of Leukemia and Abrogates BCR-ABL–Induced Evasion of Apoptosis in Part through Regulation of Forkhead Tumor Suppressors
Open the PDF for Proteasome Inhibition Causes Regression of Leukemia and Abrogates BCR-ABL–Induced Evasion of Apoptosis in Part through Regulation of Forkhead Tumor Suppressors in another window
Includes: Supplementary data
Journal Articles

BRD4-NUT: A novel oncoprotein that blocks epithelial differentiation and maintains the growth of carcinoma cells

Chris A. French, Jeffery L. Kutok, Jeffrey A. Toretsky, Ursula R. Kees, Lisa Chiu, Jennifer L. Mitchell, Jon C. Aster
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 994.
Published: 15 April 2006
View article titled, BRD4-NUT: A novel oncoprotein that blocks epithelial differentiation and maintains the growth of carcinoma cells
Journal Articles

Identification of Leukocyte E-Selectin Ligands, P-Selectin Glycoprotein Ligand-1 and E-Selectin Ligand-1, on Human Metastatic Prostate Tumor Cells

Charles J. Dimitroff, Leyla Descheny, Natalia Trujillo, Robert Kim, Vuong Nguyen, Wei Huang, Kenneth J. Pienta, Jeffery L. Kutok, Mark A. Rubin
Journal: Cancer Research
Cancer Res (2005) 65 (13): 5750–5760.
https://doi.org/10.1158/0008-5472.CAN-04-4653
Published: 01 July 2005
View article titled, Identification of Leukocyte E-Selectin Ligands, P-Selectin Glycoprotein Ligand-1 and E-Selectin Ligand-1, on Human Metastatic Prostate Tumor Cells
Open the PDF for Identification of Leukocyte E-Selectin Ligands, P-Selectin Glycoprotein Ligand-1 and E-Selectin Ligand-1, on Human Metastatic Prostate Tumor Cells in another window
Journal Articles

The MMP-9/NGAL complex plays a role in breast tumor growth and is present with high frequency in the urine of breast cancer patients

Cecilia A. Fernández, Li Yan, Gwendolyn Louis, Jiang Yang, Jeffery L. Kutok, Marsha A. Moses
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1110.
Published: 01 May 2005
View article titled, The MMP-9/NGAL complex plays a role in breast tumor growth and is present with high frequency in the urine of breast cancer patients
Journal Articles

Targeted Expression of Human MYCN Selectively Causes Pancreatic Neuroendocrine Tumors in Transgenic Zebrafish

Hong Wei Yang, Jeffery L. Kutok, Nam Hyuk Lee, Hui Ying Piao, Christopher D. M. Fletcher, John P. Kanki, A. Thomas Look
Journal: Cancer Research
Cancer Res (2004) 64 (20): 7256–7262.
https://doi.org/10.1158/0008-5472.CAN-04-0931
Published: 15 October 2004
View article titled, Targeted Expression of Human <em>MYCN</em> Selectively Causes Pancreatic Neuroendocrine Tumors in Transgenic Zebrafish
Open the PDF for Targeted Expression of Human <em>MYCN</em> Selectively Causes Pancreatic Neuroendocrine Tumors in Transgenic Zebrafish in another window
Journal Articles

JAGGED1 Expression Is Associated with Prostate Cancer Metastasis and Recurrence

Sandro Santagata, Francesca Demichelis, Alberto Riva, Sooryanarayana Varambally, Matthias D. Hofer, Jeffery L. Kutok, Robert Kim, Jeffery Tang, James E. Montie, Arul M. Chinnaiyan, Mark A. Rubin, Jon C. Aster
Journal: Cancer Research
Cancer Res (2004) 64 (19): 6854–6857.
https://doi.org/10.1158/0008-5472.CAN-04-2500
Published: 01 October 2004
View article titled, JAGGED1 Expression Is Associated with Prostate Cancer Metastasis and Recurrence
Open the PDF for JAGGED1 Expression Is Associated with Prostate Cancer Metastasis and Recurrence in another window
Includes: Supplementary data
Journal Articles

Rolling of Human Bone-Metastatic Prostate Tumor Cells on Human Bone Marrow Endothelium under Shear Flow Is Mediated by E-Selectin

Charles J. Dimitroff, Mirna Lechpammer, Denise Long-Woodward, Jeffery L. Kutok
Journal: Cancer Research
Cancer Res (2004) 64 (15): 5261–5269.
https://doi.org/10.1158/0008-5472.CAN-04-0691
Published: 02 August 2004
View article titled, Rolling of Human Bone-Metastatic Prostate Tumor Cells on Human Bone Marrow Endothelium under Shear Flow Is Mediated by E-Selectin
Open the PDF for Rolling of Human Bone-Metastatic Prostate Tumor Cells on Human Bone Marrow Endothelium under Shear Flow Is Mediated by E-Selectin in another window